Treatment of Postoperative Lymphatic Leakage Applying Transpedal Lymphangiography - Experience in 355 Consecutive Patients.

IF 1.7
Feng Pan, Goetz M Richter, Thuy Duong Do, Hans-Ulrich Kauczor, Rosa Klotz, Thilo Hackert, Martin Loos, Christof M Sommer
{"title":"Treatment of Postoperative Lymphatic Leakage Applying Transpedal Lymphangiography - Experience in 355 Consecutive Patients.","authors":"Feng Pan,&nbsp;Goetz M Richter,&nbsp;Thuy Duong Do,&nbsp;Hans-Ulrich Kauczor,&nbsp;Rosa Klotz,&nbsp;Thilo Hackert,&nbsp;Martin Loos,&nbsp;Christof M Sommer","doi":"10.1055/a-1717-2467","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Report of experience from a single institution in treating postoperative lymphatic leakage (PLL) applying conventional transpedal lymphangiography (TL).</p><p><strong>Materials and methods: </strong>453 patients with the initial diagnosis of PLL receiving TL between 03/1993 and 09/2018 were identified in the database. Only patients with confirmed PLL were included in the study. The technical success, safety, and treatment success of TL were evaluated. Independent predictors of TL treatment failure were examined using univariate and multivariate logistic regression analysis.</p><p><strong>Results: </strong>355 consecutive patients (218 men, 137 women; median age of 62 years) who underwent TL for PLL (e. g., chylothorax) after ineffective conservative treatment were included. The median time between causal surgery and TL was 27 days. The median technical success rate of TL was 88.5 %, with a median volume of Lipiodol of 10.0 ml. No complication of TL was recorded. Three groups were defined according to the different clinical courses: group A (41/355, 11.5 %) - TL with technical failure; group B (258/355, 72.7 %) - \"therapeutic\" TL alone with technical success; and group C (56/355, 15.8 %) - \"diagnostic\" TL with simultaneously invasive treatment (incl. surgical revision and percutaneous sclerotherapy). Treatment success rate and median time to treatment success were higher in group C than in group B, but without significant differences (64.3 % vs. 61.6 %, p = 0.710; six vs. five days, p = 0.065). Univariate and multivariate logistic regression analyses for group B confirmed drainage volume (> 500 ml/d) and Lipiodol extravasation as independent predictors of TL clinical failure (odds ratios [ORs] of 2.128 and 2.372 [p = 0.005 and p = 0.003, respectively]).</p><p><strong>Conclusion: </strong>TL is technically reliable, safe, and effective in treating PLL. When conservative treatment fails, TL can be regarded as the next treatment option.</p><p><strong>Key points: </strong>· TL is technically reliable, safe, and effective for treating PLL.. · When conservative treatment fails, TL can be regarded as the next treatment option.. · Drainage volume > 500 ml/day is an independent predictor of clinical failure after TL.. · Lipiodol extravasation is an independent predictor of clinical failure after TL..</p><p><strong>Citation format: </strong>· Pan F, Richter GM, Do TD et al. Treatment of Postoperative Lymphatic Leakage Applying Transpedal Lymphangiography - Experience in 355 Consecutive Patients. Fortschr Röntgenstr 2022; 194: 634 - 643.</p>","PeriodicalId":520772,"journal":{"name":"RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin","volume":" ","pages":"634-643"},"PeriodicalIF":1.7000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1717-2467","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Purpose: Report of experience from a single institution in treating postoperative lymphatic leakage (PLL) applying conventional transpedal lymphangiography (TL).

Materials and methods: 453 patients with the initial diagnosis of PLL receiving TL between 03/1993 and 09/2018 were identified in the database. Only patients with confirmed PLL were included in the study. The technical success, safety, and treatment success of TL were evaluated. Independent predictors of TL treatment failure were examined using univariate and multivariate logistic regression analysis.

Results: 355 consecutive patients (218 men, 137 women; median age of 62 years) who underwent TL for PLL (e. g., chylothorax) after ineffective conservative treatment were included. The median time between causal surgery and TL was 27 days. The median technical success rate of TL was 88.5 %, with a median volume of Lipiodol of 10.0 ml. No complication of TL was recorded. Three groups were defined according to the different clinical courses: group A (41/355, 11.5 %) - TL with technical failure; group B (258/355, 72.7 %) - "therapeutic" TL alone with technical success; and group C (56/355, 15.8 %) - "diagnostic" TL with simultaneously invasive treatment (incl. surgical revision and percutaneous sclerotherapy). Treatment success rate and median time to treatment success were higher in group C than in group B, but without significant differences (64.3 % vs. 61.6 %, p = 0.710; six vs. five days, p = 0.065). Univariate and multivariate logistic regression analyses for group B confirmed drainage volume (> 500 ml/d) and Lipiodol extravasation as independent predictors of TL clinical failure (odds ratios [ORs] of 2.128 and 2.372 [p = 0.005 and p = 0.003, respectively]).

Conclusion: TL is technically reliable, safe, and effective in treating PLL. When conservative treatment fails, TL can be regarded as the next treatment option.

Key points: · TL is technically reliable, safe, and effective for treating PLL.. · When conservative treatment fails, TL can be regarded as the next treatment option.. · Drainage volume > 500 ml/day is an independent predictor of clinical failure after TL.. · Lipiodol extravasation is an independent predictor of clinical failure after TL..

Citation format: · Pan F, Richter GM, Do TD et al. Treatment of Postoperative Lymphatic Leakage Applying Transpedal Lymphangiography - Experience in 355 Consecutive Patients. Fortschr Röntgenstr 2022; 194: 634 - 643.

经趾淋巴管造影治疗术后淋巴漏——355例患者的经验。
目的:报告某医院应用常规经趾淋巴管造影(TL)治疗术后淋巴渗漏(PLL)的经验。材料与方法:从数据库中确定1993年3月至2018年9月间首次诊断为PLL并接受TL治疗的患者453例。只有确诊的PLL患者被纳入研究。对TL的技术成功、安全性和治疗成功率进行评价。采用单因素和多因素logistic回归分析检验TL治疗失败的独立预测因素。结果:355例连续患者(218例男性,137例女性;中位年龄62岁),因PLL接受TL治疗(例如:包括保守治疗无效后的乳糜胸。从因果手术到TL的中位时间为27天。TL的中位技术成功率为88.5%,中位油体积为10.0 ml。TL无并发症记录。根据不同的临床病程分为三组:A组(41/ 3555,11.5%)- TL合并技术失败;B组(258/355,72.7%)-单纯“治疗性”TL且技术成功;C组(56/ 3555,15.8%)——“诊断性”TL同时进行有创治疗(包括手术翻修和经皮硬化治疗)。C组治疗成功率和中位治疗成功时间均高于B组,但无显著差异(64.3% vs 61.6%, p = 0.710;6天vs. 5天,p = 0.065)。单因素和多因素logistic回归分析证实B组引流量(> 500 ml/d)和Lipiodol外渗是TL临床失败的独立预测因素(优势比[or]分别为2.128和2.372 [p = 0.005和p = 0.003])。结论:TL治疗PLL技术可靠、安全、有效。当保守治疗失败时,TL可作为下一个治疗选择。·TL治疗PLL技术可靠、安全、有效。·保守治疗失败时,TL可作为下一个治疗方案。·引流量> 500 ml/天是TL术后临床失败的独立预测指标。·脂醇外渗是TL术后临床失败的独立预测因子。引用格式:·Pan F, Richter GM, Do TD等。经趾淋巴管造影治疗术后淋巴漏——355例患者的经验。Fortschr Röntgenstr 2022;[194]: 634 - 643。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书